Product Images Zarontin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Zarontin NDC 0071-2418 by Parke-davis Div Of Pfizer Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - zarontin 01

Chemical Structure - zarontin 01

Company Logo - zarontin 02

Company Logo - zarontin 02

Sefizer is a product that is distributed by Parke-Davis, which is a division of Pfizer Inc. The company is located in New York, NY 10017.*

Logo - zarontin 02a

Logo - zarontin 02a

Sefizer is a product or brand name that is distributed by Parke-Davis, which is a division of Pfizer Inc. located in New York, NY 10017.*

PRINCIPAL DISPLAY PANEL - 474 mL Bottle Label - 2418-23 - zarontin 03

PRINCIPAL DISPLAY PANEL - 474 mL Bottle Label - 2418-23 - zarontin 03

This is a medication guide for Zarontin® oral solution, containing 250mg per 5 liters of Ethosuximide in a raspberry flavored base. It is recommended to always dispense medication with the accompanying medication guide. The solution should be stored at 20°-25°C (66°-77°F) in tight containers and protected from freezing and light. The dispensing container must be child-resistant and light-resistant as defined in the USP. For dosage and use, please refer to the accompanying prescribing information. This medication is distributed by Parke-Davis Division of Pize Inc, NY, NY 10017. No other details are available from the given text.*

PRINCIPAL DISPLAY PANEL - 474 mL Bottle Carton - 2418-23 - zarontin 04

PRINCIPAL DISPLAY PANEL - 474 mL Bottle Carton - 2418-23 - zarontin 04

This is a description of a medication called Zarontin® which is distributed by Parke-Davies. It contains the active ingredient Ethosuximide and is available in oral solution form. Each 5 mL of oral solution contains 250 mg of Ethosuximide. The medication is dispensed in a tight and resistant container and has a rispberry flavor. There are contact details for Parke-Davies included, and the medication is available in divisons of 1 Pint (474 L).*

PRINCIPAL DISPLAY PANEL - 474 mL Bottle Label - 2418-35 - zarontin 05

PRINCIPAL DISPLAY PANEL - 474 mL Bottle Label - 2418-35 - zarontin 05

Zarontin is an oral solution medication containing Ethosuximide. Each 5mL of this raspberry-flavored base medication contains 250mg of ethosuximide. The medication guide should always be dispensed with this medication. The medication should be stored at a temperature ranging from 20°C-25°C (68°F-77°F), in tightly sealed, light-resistant and child-resistant containers. The medication should be protected from freezing and light. Please see the accompanying prescribing information for the dosage and usage directions. This medication is distributed by Parke-Davis, a division of Pfizer Inc in NY, NY.*

PRINCIPAL DISPLAY PANEL - 474 mL Bottle Carton - 2418-35 - zarontin 06

PRINCIPAL DISPLAY PANEL - 474 mL Bottle Carton - 2418-35 - zarontin 06

This is a description for a medication called Zarontin® (Ethosuximide) in the form of an oral solution, distributed by Parke-Davis Division of Pfizer Inc in New York. The solution comes in raspberry flavor and each 5 mL of oral solution contains 250 mg ethosuximide. The prescription information should be consulted for dosage and use instructions. The medication should be dispensed and stored in tight and light-resistant child-resistant containers.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.